SC 13D Filing

Company

Stoke Therapeutics, Inc.

Filed

June 30, 2021

Accession Number

0001123292-21-001063

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →